Prof. Dr. Jianliu Wang, Peking University, Beijing, China
Jianliu Wang is a distinguished gynecologist, researcher, and academic leader. Currently serving as Vice-President of Peking University People’s Hospital, he is also the Chairman and Professor of the Department of Obstetrics and Gynecology. As an expert in gynecologic oncology and pelvic disorders, he has significantly contributed to medical research and clinical advancements. His pioneering studies on cervical and endometrial cancer have influenced treatment protocols and improved patient outcomes. He has also played a crucial role in advancing pelvic floor disorder treatments. Dr. Wang holds key positions in prestigious medical associations, including the International Urogynecology Association and the International Gynecological Cancer Society. He is the Chief Editor of Gynecology and Obstetrics Clinical Medicine and has received numerous accolades for his contributions to medical science. His dedication to research, education, and patient care continues to shape the future of gynecological health worldwide.
Professional Profile
Scopus
Orcid
Suitability for the Research for Best Researcher Award – Jianliu Wang
Prof. Jianliu Wang is an outstanding candidate for the Research for Best Researcher Award based on his extensive contributions to gynecologic oncology, pelvic floor disorders, and female reproductive health. His distinguished career spans multiple decades, with leadership roles as Vice-President of Peking University People’s Hospital, Chairman of the Obstetrics and Gynecology Department, and Chairman of the National Center for Pelvic Diseases Control. These positions demonstrate his leadership in both clinical practice and medical research.
His academic background is impressive, with degrees from Henan Medical University and Beijing Medical University, alongside specialized training at Karolinska Hospital in Sweden. His research focuses on gynecologic oncology, particularly cervical and endometrial cancer, with groundbreaking work on biomarkers such as p16INK4a, p14ARF, and p53. His findings have been published in high-impact journals, including Clinical Cancer Research, Oncogene, Cell Death & Disease, and Gynecologic Oncology. His research also extends to the metabolic microenvironment of endometrial cancer, demonstrating his multidisciplinary approach to understanding and treating gynecologic malignancies.
🎓 Education
Dr. Jianliu Wang pursued his medical education at Henan Medical University, where he earned his Bachelor of Science degree in Clinical Medicine in 1986. He further specialized in Gynecologic Oncology, obtaining his M.D. from the same institution in 1991. His commitment to research and academic excellence led him to earn a Ph.D. in Gynecologic Oncology from Beijing Medical University in 1998. Seeking international expertise, he advanced his studies at Karolinska Hospital in Stockholm, Sweden, from 2002 to 2004. His extensive training and multidisciplinary education have positioned him as a leading figure in gynecologic oncology research and clinical practice. His academic journey reflects his relentless pursuit of knowledge and innovation, which he has applied to improving women’s healthcare globally.
💼 Professional Experience
Dr. Jianliu Wang has an illustrious career spanning decades in obstetrics and gynecology. Since 2004, he has served as a Professor in the Department of Obstetrics and Gynecology at Peking University People’s Hospital. His leadership capabilities led to his appointment as Chairman of the department in 2014 and Vice-President of the hospital in 2016. Beyond his clinical and academic roles, Dr. Wang has significantly contributed to professional societies, serving as a board member of the International Society for Gynecologic Endoscopy and a standing committee member of various medical associations. His influence extends to medical research, where he has led groundbreaking studies in gynecologic oncology and pelvic floor disorders. As Chief Editor of Gynecology and Obstetrics Clinical Medicine, he has shaped medical literature and guided future research. His expertise and leadership continue to drive innovations in gynecological healthcare worldwide.
🏅 Awards and Recognition
Dr. Jianliu Wang has received numerous prestigious awards recognizing his contributions to gynecologic oncology and pelvic disorder research. In 2024, he was honored with the China Medical Science and Technology Award. His groundbreaking work on the microenvironment and molecular pathogenesis of endometrial carcinoma earned him the First Class Prize from the China Medical Science and Technology Award in 2018. That same year, he won the First Class Prize from the Beijing Medical Science Award. His research excellence has also been acknowledged with the Science Research Famous Achievement Award and the Huaxia Medical Science Award. In 2015, he received the Science Technology Award from the Chinese Association of Plastics and Aesthetics. His international reputation was further solidified by the 2012 Wu Jieping Medical Research Award and Paul Janssen Pharmacy Research Award. Dr. Wang’s relentless dedication to gynecological research has left an indelible impact on global healthcare.
🌍 Research Skills On Gynecology
Dr. Jianliu Wang is a leading researcher in gynecologic oncology and pelvic organ disorders. His expertise spans molecular pathogenesis, tumor microenvironment analysis, and translational research in cervical and endometrial cancers. He has pioneered biomarker discovery for cancer diagnosis and has developed innovative prognostic models using clinical and genomic data. His work on calcium signaling and metabolic pathways in cancer progression has been widely cited. Additionally, Dr. Wang has extensively studied pelvic organ prolapse, focusing on epidemiology, biomechanical properties, and surgical outcomes. He integrates clinical expertise with research, bridging gaps between laboratory discoveries and patient treatments. His research, published in top-tier journals, has influenced medical guidelines and improved gynecological healthcare practices worldwide. His ability to synthesize multidisciplinary knowledge into groundbreaking medical advancements cements his reputation as a foremost expert in the field.
Publication Top Notes
-
Title: A 14-year multi-institutional collaborative study of Chinese pelvic floor surgical procedures related to pelvic organ prolapse
- Authors: Sun, Z.-J.; Wang, X.-Q.; Lang, J.-H.; Xu, T.; Lu, Y.-X.; Hua, K.-Q.; Han, J.-S.; Li, H.-F.; Tong, X.-W.; Wang, P. et al.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1097/CM9.0000000000001237
-
Title: A novel transcription factor-based prognostic signature in endometrial cancer: Establishment and validation
- Authors: Yang, X.; Cheng, Y.; Li, X.; Zhou, J.; Dong, Y.; Shen, B.; Zhao, L.; Wang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.2147/OTT.S293085
-
Title: A ten-gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer
- Authors: Li, X.; Yang, X.; Fan, Y.; Cheng, Y.; Dong, Y.; Zhou, J.; Wang, Z.; Li, X.; Wang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1016/j.ygeno.2021.04.035
-
Title: A Training Simulator for Fractional Dilation and Curettage With Visualized Force-Position Feedback and Quantitative Evaluation
- Authors: Zheng, Y.; Wang, K.; Zhang, K.; An, J.; Wu, J.; Feng, Z.; Liu, C.; Wang, J.; Lu, Q.; Zhang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1097/AOG.0000000000004443
-
Title: Acceleration of pelvic tissue generation by overexpression of basic fibroblast growth factor in stem cells
-
Title: Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
- Authors: Fan, Y.; Li, X.; Wang, J.; Wang, Y.; Tian, L.; Wang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1186/s12958-021-00808-y
-
Title: Assessment of Pelvic Floor Function and Quality of Life in Patients Treated for Cervical Cancer: A Multicenter Retrospective Study
- Authors: Wang, S.; Wen, H.; Gao, Y.; Lv, Q.; Cao, T.; Wang, S.; Wang, J.; Li, Y.; Wang, H.; Wang, Z. et al.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1159/000517995
-
Title: Association of pelvic floor function with postoperative urinary incontinence in cervical cancer patients after the radical hysterectomy
- Authors: Wang, S.; Wang, R.; Wen, H.; Gao, Y.; Lv, Q.; Li, H.; Wang, S.; Wang, Y.; Liu, Q.; Han, J. et al.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1002/nau.24587
-
Title: Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma
- Authors: Liang, S.; Wang, Z.; Chen, J.; Yang, X.; Liang, X.; Sun, X.; Li, X.; Zhou, R.; Li, Y.; Wang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1002/jso.26518
-
Title: Cutaneous metastases of endometrial carcinoma: report of an unusual case and literature review
- Authors: Fan, Y.; Deng, H.; Tian, L.; Wang, J.
- Year: 2021
- Citations: [Check Scopus for citation count]
- DOI: 10.1007/s00404-021-06165-w